According to Crohn’s & Colitis UK, around 300,000 people suffer from crohn’s disease and ulcerative colitis in the UK annually.
According to Crohn’s & Colitis UK, around 300,000 people suffer from crohn’s disease and ulcerative colitis in the UK annually.[1] Malnourishment is the common cause of inflammatory bowel disease (IBD) among a large section of people in both under-developed and developing countries. On a larger perspective, total parenteral nutrition (TPN) serves as a primary treatment for IBD by restoring the nutritional deficiency caused due to resultant intestinal failure. Parenteral nutrition therapy is gaining wide recognition in the medical sector since it is helpful in treating gastrointestinal disorders and cancer. The global parenteral nutrition market is experiencing a demand upsurge owing to the rising malnourished population. The global parenteral nutrition market generated $4.3 billion in revenue in 2018. Growing awareness programs initiated both by the governmental and private organizations have increased knowledge about chronic diseases among the mass, thereby escalating the parenteral nutrition market scope. The market is evaluated to grow at a compound annual growth rate (CAGR) of 3.47% through 2025.
Approximately 40 million Americans suffer from hunger in the U.S., which also includes more than 12 million children as per Feeding America.[2] This statistics is reflective of the impending diseases associated with malnourishment, which is one of the leading causative factors for the incrementing demand for parenteral nutrition in North America. The region contributed a generous share of 36.30% to the global market in 2018. Poor dietary conditions and increasing inborn errors of nutrient deficiency have opened up huge opportunities for single-dose amino acid solutions. The single-dose amino acid solutions is projected to grow at a CAGR of 3.65% during the forecast period 2019--2025.
Parenteral Nutrition Market Growth Drivers:
· The global burden of malnutrition and unhealthy lifestyle of people majorly propel the parenteral nutrition market growth.
· Rapid urbanization, compromised intake of balanced nutritional diet, and incessantly rising chronic disease incidences also fuel the parenteral nutrition demand.
Parenteral Nutrition Market Key Players:
The leading companies in the parenteral nutrition market includes B. Braun Melsungen AG, Otsuka Pharmaceutical Factory Inc., Baxter International Inc., Allergan plc. (Actavis plc.), Grifols S.A.,Pfizer Inc., Sichuan Kelun Pharmaceutical Co. Ltd., Claris Lifesciences Limited, Fresenius SE & Co. KGaA, and others.
Otsuka Pharmaceutical Factory Inc. delivers various parenteral nutrition products including Celemin, Celepid MCT-LCT, TNA/TNA-Peri, Celemix, and Elemun to the leading hospitals and clinics.
Parenteral Nutrition Market Trends:
· Fatty Acid Parenteral Nutrition:
A recent innovation in the parenteral nutrition market is the injecting of fatty acids obtained from fish oil triglycerides into the elderly population to improve liver functioning and increase the plasma platelet count. This method can considerably help restore the glucose and nutritional level in post-surgical patients.
· Olive Oil-Based Parenteral Nutrition
Additionally, administration of ready-to-use products, such as olive oil, along with parenteral nutrition is a revolutionary process introduced by the Baxter International Inc. to offer solution to the high stress patients.
Parenteral Nutrition Market Research Scope:
The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the Parenteral Nutrition market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of Parenteral Nutrition in the Parenteral Nutrition market, and their specific applications in different areas.
Parenteral Nutrition Market: Industry Coverage:
The global parenteral nutrition market is basically classified on the basis of product type. Sub segments under product type include carbohydrates, parenteral lipid emulsion, single dose amino acid solution, trace elements, vitamins, minerals, and others.
The Parenteral Nutrition market also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:
• North America: The U.S., Canada, Mexico
• South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica
• Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark
• APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong
• Middle East and Africa: Israel, South Africa, Saudi Arabia
Reference:
[1] https://www.crohnsandcolitis.org.uk
[2] https://www.feedingamerica.org
Approximately 40 million Americans suffer from hunger in the U.S., which also includes more than 12 million children as per Feeding America.[2] This statistics is reflective of the impending diseases associated with malnourishment, which is one of the leading causative factors for the incrementing demand for parenteral nutrition in North America. The region contributed a generous share of 36.30% to the global market in 2018. Poor dietary conditions and increasing inborn errors of nutrient deficiency have opened up huge opportunities for single-dose amino acid solutions. The single-dose amino acid solutions is projected to grow at a CAGR of 3.65% during the forecast period 2019--2025.
Parenteral Nutrition Market Growth Drivers:
· The global burden of malnutrition and unhealthy lifestyle of people majorly propel the parenteral nutrition market growth.
· Rapid urbanization, compromised intake of balanced nutritional diet, and incessantly rising chronic disease incidences also fuel the parenteral nutrition demand.
Parenteral Nutrition Market Key Players:
The leading companies in the parenteral nutrition market includes B. Braun Melsungen AG, Otsuka Pharmaceutical Factory Inc., Baxter International Inc., Allergan plc. (Actavis plc.), Grifols S.A.,Pfizer Inc., Sichuan Kelun Pharmaceutical Co. Ltd., Claris Lifesciences Limited, Fresenius SE & Co. KGaA, and others.
Otsuka Pharmaceutical Factory Inc. delivers various parenteral nutrition products including Celemin, Celepid MCT-LCT, TNA/TNA-Peri, Celemix, and Elemun to the leading hospitals and clinics.
Parenteral Nutrition Market Trends:
· Fatty Acid Parenteral Nutrition:
A recent innovation in the parenteral nutrition market is the injecting of fatty acids obtained from fish oil triglycerides into the elderly population to improve liver functioning and increase the plasma platelet count. This method can considerably help restore the glucose and nutritional level in post-surgical patients.
· Olive Oil-Based Parenteral Nutrition
Additionally, administration of ready-to-use products, such as olive oil, along with parenteral nutrition is a revolutionary process introduced by the Baxter International Inc. to offer solution to the high stress patients.
Parenteral Nutrition Market Research Scope:
The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the Parenteral Nutrition market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of Parenteral Nutrition in the Parenteral Nutrition market, and their specific applications in different areas.
Parenteral Nutrition Market: Industry Coverage:
The global parenteral nutrition market is basically classified on the basis of product type. Sub segments under product type include carbohydrates, parenteral lipid emulsion, single dose amino acid solution, trace elements, vitamins, minerals, and others.
The Parenteral Nutrition market also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:
• North America: The U.S., Canada, Mexico
• South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica
• Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark
• APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong
• Middle East and Africa: Israel, South Africa, Saudi Arabia
Reference:
[1] https://www.crohnsandcolitis.org.uk
[2] https://www.feedingamerica.org
